Ipca Laboratories Ltd Quarterly Results

Gross Sales

2,245.37

2,354.9

2,092.63

2,033.03

2,052.85

Excise Duty

0

0

0

0

0

Net Sales

2,245.37

2,354.9

2,092.63

2,033.03

2,052.85

Other Operating Income

0

0

0

0

0

Other Income

20.11

26.26

20.61

18.92

90.91

Total Income

2,265.48

2,381.16

2,113.24

2,051.95

2,143.76

Total Expenditure

1,782.29

1,913.42

1,699.91

1,847.85

1,721.97

PBIDT

483.19

467.74

413.33

204.1

421.79

Interest

16.81

22.56

24.05

29.37

33.4

PBDT

466.38

445.18

389.28

174.73

388.39

Depreciation

98.46

100.35

98.89

98.13

99.5

Minority Interest Before NP

0

0

0

0

0

Tax

100.62

97.9

84.46

71.82

66.53

Deferred Tax

-10.03

1.49

6.95

1.87

-0.29

Reported Profit After Tax

277.33

245.44

198.98

2.91

222.65

Minority Interest After NP

28.22

16.27

6.9

-58.26

41.12

Net Profit after Minority Interest

248.14

229.48

192.24

59.59

179.88

Extra-ordinary Items

0

0

0

-63.03

52.69

Adjusted Profit After Extra-ordinary item

248.14

229.48

192.24

122.62

127.19

EPS (Unit Curr.)

9.78

9.05

7.58

2.35

7.09

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

200

0

0

0

Equity

25.37

25.37

25.37

25.37

25.37

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.51

19.86

19.75

10.03

20.54

PBDTM(%)

20.77

18.9

18.6

8.59

18.91

PATM(%)

12.35

10.42

9.5

0.14

10.84